Work

Low Dose Clofarabine Causes Significant Hematologic Toxicity in a Phase II Study of Relapsed or Refractory Multiple Myeloma.

Year: 2005

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v106.11.5170.5170

Authors: Geoffrey L. Uy, Alisa M. Ruddell, Steven M. Devine, Michael H. Tomasson, John F. DiPersio, Ravi Vij

Institution: Washington University in St. Louis

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2555770141

FWCI:

Cites:

Cited by:

Related to: 10